Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
China Resources Double-Crane: Controlling subsidiary’s sodium valproate oral solution has obtained the drug registration certificate
People’s Financial News, March 17 — China Resources Double-Crane (600062) announced on March 17 that its controlling subsidiary, Xiangzhong Pharmaceutical, has received the drug registration certificate for sodium valproate oral solution issued by the National Medical Products Administration. Sodium valproate oral solution is used for generalized, partial, or other types of epilepsy.